Why is Link Pharma Chem falling/rising?

As of 08-Sep, Link Pharma Chem Ltd is experiencing a decline in its stock price, currently at 34.75, which reflects a decrease of 0.75 or 2.11%. The stock has underperformed its sector by 2.62% today, and while it is higher than its 5-day moving average, it remains below the 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 69.49% compared to the 5-day average. The stock has shown poor performance over various periods, with a year-to-date decline of 15.24% and a one-year return of -20.82%. The company's weak long-term fundamentals, highlighted by a -183.49% CAGR growth in operating profits over the last five years and a low return on equity of 5.21%, further contribute to its negative price movement.
In the broader market context, the Sensex has shown a positive return of 0.53% over the past week, contrasting sharply with Link Pharma Chem's decline of 3.20% during the same period. This underperformance is indicative of the company's struggles, as it has consistently lagged behind the benchmark over the last three years, one year, and three months. The company's flat results in net sales and negative operating profits, alongside a poor EBIT to interest ratio, suggest significant financial challenges that are likely influencing investor sentiment and leading to the stock's downward trajectory.